spacer
home > ebr > spring 2002 > striking a 'work-life balance' in the pharmaceutical industry
PUBLICATIONS
European Biopharmaceutical Review

Striking a 'Work-Life Balance' in the Pharmaceutical Industry

'Work-life balance' - 10 years ago this phrase was virtually unheard of and the idea of staggered hours, flexible locations and job sharing would have baffled most managers. However, times have changed. Over the last decade there has been a major shift in the workplace; old methods of working no longer suit everyone, and work-life balance practices are becoming more and more relevant. The modern workforce is increasingly sophisticated and employees know their value as well as their rights and responsibilities at work. The wide range of family, work and life commitments that many people shoulder mean that attitudes to work have changed. As a result, employers can no longer assume that all their staff will consistently work traditional and inflexible work patterns.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Alan Johnson, Minister of State for Employer Relations at the Department of Trade and Industry

Alan Johnson is Minister of State at the Department of Trade and Industry with responsibility for Employment Relations. He was elected MP for Kingston-upon-Hull West and Hessle in 1997 and was also a member of the Trade and Industry Select Committee in 1997.
Alan was previously Parliamentary Private Secretary to Dawn Primarolo MP, the Paymaster General, and Parliamentary Under Secretary of State for Competitiveness at the DTI. He was a member of the General Council TUC between 1994 and 1995, and a member of the Labour Party NEC from 1995 to 1997.

spacer
Alan Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Maetrics appoints Dr Amie Smirthwaite to lead Clinical Practice discipline globally

Maetrics, an international leader in life sciences quality and regulatory consulting, has appointed Dr Amie Smirthwaite as Senior Director of the Global Clinical Practice.
More info >>

White Papers

The Importance of ADCC in Assessing Clinically Relevant Differences

Sartorius Stedim BioOutsource Ltd

Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement